$ORKA
Market Cap:
$34.82 Million
Financial Snapshot
Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$34.38M
TTM
Current Ratio
2289.2%
Q3 2024
Book Value
$395.2M
Q3 2024
P/E
-1.013
Nov 29, 2024 EST
Free Cash Flow
-$1.056M
TTM
Revenues
Revenues
Loading...
Loading...
Revenue YoY Change
Loading...
Loading...
Revenues
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $46.86M | $3.890M | $550.0K | $200.0K | $1.020M | $25.55M | $24.59M | $15.60M | $6.400M | $9.590M | $6.200M | $430.0K | $2.130M |
| YoY Change | -100.0% | 1104.63% | 607.27% | 175.0% | -80.39% | -96.01% | 3.9% | 57.63% | 143.75% | -33.26% | 54.68% | 1341.86% | -79.81% | 4160.0% |
Expenses
Cost Of Revenues
Loading...
Loading...
Gross Profit
Loading...
Loading...
Gross Profit Margin
Loading...
Loading...
Gross Profit
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $46.86M | $3.890M | $550.0K | $200.0K | $1.020M | $25.55M | $24.59M | $15.60M | $6.400M | $9.590M | $6.200M | $430.0K | $2.130M |
| Cost Of Revenue | |||||||||||||||||||||||||||||
| Gross Profit | |||||||||||||||||||||||||||||
| Gross Profit Margin |
Selling, General & Admin Expense
Loading...
Loading...
Research & Development
Loading...
Loading...
Depreciation, Depletion & Amortization
Loading...
Loading...
SGA Expense to Gross Profit Ratio
Loading...
Loading...
R&D To Gross Profit Ratio
Loading...
Loading...
DDA To Gross Profit Ratio
Loading...
Loading...
Operating Expenses Total
Loading...
Loading...
Operating Profits/Loss
Loading...
Loading...
Operational Expenses
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General & Admin | $6.283M | $5.847M | $5.503M | $4.770M | $3.980M | $3.880M | $4.640M | $4.270M | $4.390M | $4.070M | $4.010M | $3.230M | $5.050M | $6.070M | $12.84M | $8.470M | $20.76M | $55.09M | $15.80M | $8.700M | $15.07M | $14.98M | $13.45M | $9.320M | $8.100M | $9.500M | $4.850M | $1.750M | $940.0K |
| YoY Change | 7.46% | 6.25% | 15.37% | 19.85% | 2.58% | -16.38% | 8.67% | -2.73% | 7.86% | 1.5% | 24.15% | -36.04% | -16.8% | -52.73% | 51.59% | -59.2% | -62.32% | 248.67% | 81.61% | -42.27% | 0.6% | 11.38% | 44.31% | 15.06% | -14.74% | 95.88% | 177.14% | 86.17% | -36.49% |
| % of Gross Profit | |||||||||||||||||||||||||||||
| Research & Development | $1.013M | $4.749M | $13.83M | $4.992M | $1.833M | $4.239M | $14.08M | $12.35M | $7.063M | $5.625M | $2.930M | $1.090M | $2.320M | $3.110M | $10.01M | $11.03M | $42.65M | $89.37M | $57.78M | $39.97M | $30.01M | $46.83M | $46.51M | $29.02M | $18.16M | $19.21M | $9.430M | $3.740M | $1.810M |
| YoY Change | -78.67% | -65.67% | 177.08% | 172.34% | -56.76% | -69.89% | 14.03% | 74.83% | 25.56% | 91.98% | 168.81% | -53.02% | -25.4% | -68.93% | -9.25% | -74.14% | -52.28% | 54.67% | 44.56% | 33.19% | -35.92% | 0.69% | 60.27% | 59.8% | -5.47% | 103.71% | 152.14% | 106.63% | 112.94% |
| % of Gross Profit | |||||||||||||||||||||||||||||
| Depreciation & Amortization | $15.00K | $20.00K | $16.00K | $10.00K | $20.00K | $20.00K | $30.00K | $20.00K | $20.00K | $10.00K | $26.00K | $43.00K | $600.0K | $340.0K | $460.0K | $220.0K | $2.340M | $3.180M | $2.670M | $4.120M | $5.530M | $6.250M | $5.070M | $3.100M | $2.880M | $1.690M | $920.0K | $440.0K | $290.0K |
| YoY Change | -25.0% | 25.0% | 60.0% | -50.0% | 0.0% | -33.33% | 50.0% | 0.0% | 100.0% | -61.54% | -39.53% | -92.83% | 76.47% | -26.09% | 109.09% | -90.6% | -26.42% | 19.1% | -35.19% | -25.5% | -11.52% | 23.27% | 63.55% | 7.64% | 70.41% | 83.7% | 109.09% | 51.72% | 222.22% |
| % of Gross Profit | |||||||||||||||||||||||||||||
| Operating Expenses | $7.296M | $10.60M | $19.34M | $9.766M | $5.814M | $8.118M | $18.71M | $12.35M | $11.46M | $9.693M | $6.940M | $4.320M | $7.360M | $9.180M | $28.32M | $19.49M | $63.41M | $144.5M | $73.58M | $48.67M | $45.08M | $61.81M | $59.95M | $38.33M | $26.26M | $28.70M | $14.28M | $5.490M | $2.750M |
| YoY Change | -31.14% | -45.2% | 97.98% | 67.97% | -28.38% | -56.61% | 51.52% | 7.8% | 18.18% | 39.67% | 60.65% | -41.3% | -19.83% | -67.58% | 45.31% | -69.26% | -56.11% | 96.33% | 51.18% | 7.96% | -27.07% | 3.1% | 56.4% | 45.96% | -8.5% | 100.98% | 160.11% | 99.64% | 18.03% |
| Operating Profit | -$7.296M | -$10.60M | -$19.34M | -$9.766M | -$5.814M | -$11.46M | -$9.693M | ||||||||||||||||||||||
| YoY Change | -31.14% | -45.2% | 97.98% | 67.97% | 18.18% |
Interest Expenses
Loading...
Loading...
Interest Expenses To Operating Income %
Loading...
Loading...
Other Expense/Income
Loading...
Loading...
Interest & Other Expense/Income
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Expense | $1.957M | $675.0K | $13.00K | $9.000K | $7.000K | $8.000K | $6.000K | $170.0K | $4.000K | $3.000K | $4.000K | $0.00 | $0.00 | $760.0K | $25.31M | $60.00K | $6.590M | $7.800M | $1.150M | $1.530M | -$660.0K | -$1.160M | -$570.0K | $480.0K | $1.310M | $2.740M | $1.550M | $220.0K | $20.00K |
| YoY Change | 189.93% | 5092.31% | 44.44% | 28.57% | -12.5% | 33.33% | -96.47% | 4150.0% | 33.33% | -25.0% | -100.0% | -97.0% | 42083.33% | -99.09% | -15.51% | 578.26% | -24.84% | -331.82% | -43.1% | 103.51% | -218.75% | -63.36% | -52.19% | 76.77% | 604.55% | 1000.0% | 0.0% | ||
| % of Operating Profit | |||||||||||||||||||||||||||||
| Other Income/Expense, Net | $0.00 | -$5.000K | $0.00 | $270.0K | -$1.830M | -$290.0K | |||||||||||||||||||||||
| YoY Change | -100.0% | -114.75% | 531.03% |
Income/Loss
Pretax Income
Loading...
Loading...
Income Tax
Loading...
Loading...
Net Profits/Loss
Loading...
Loading...
Pretax Income YoY Change
Loading...
Loading...
Income Tax Rate
Loading...
Loading...
Net Profits/Loss YoY Change
Loading...
Loading...
Basic EPS
Loading...
Loading...
Net Income To Revenue Ratio
Loading...
Loading...
Pretax & Net Income
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pretax Income | -$5.339M | -$9.926M | -$19.32M | -$9.747M | -$5.650M | -$7.960M | -$18.55M | -$16.44M | -$11.45M | -$9.690M | -$6.939M | -$4.320M | -$5.360M | -$8.420M | -$11.42M | -$19.43M | -$12.30M | -$132.8M | -$71.61M | -$48.94M | -$46.23M | -$39.51M | -$36.77M | -$22.25M | -$18.55M | -$16.37M | -$6.540M | -$4.840M | -$600.0K |
| YoY Change | -46.21% | -48.63% | 98.24% | 72.51% | -29.02% | -57.09% | 12.83% | 43.58% | 18.16% | 39.65% | 60.63% | -19.4% | -36.34% | -26.27% | -41.22% | 57.97% | -90.74% | 85.42% | 46.32% | 5.86% | 17.01% | 7.45% | 65.26% | 19.95% | 13.32% | 150.31% | 35.12% | 706.67% | -73.45% |
| Income Tax | $0.00 | $0.00 | $0.00 | -$9.000K | -$167.0K | -$30.00K | -$60.00K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$2.280M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| % Of Pretax Income | |||||||||||||||||||||||||||||
| Net Earnings | -$5.339M | -$9.926M | -$19.32M | -$9.740M | -$5.480M | -$7.933M | -$18.49M | -$16.44M | -$11.45M | -$9.689M | -$6.939M | -$4.320M | -$5.364M | -$8.420M | -$9.138M | -$19.43M | -$13.99M | -$5.241M | -$1.459M | -$511.0K | -$50.19M | -$44.98M | -$36.47M | -$22.25M | -$18.55M | -$16.37M | -$6.540M | -$4.840M | -$600.0K |
| YoY Change | -46.21% | -48.63% | 98.38% | 77.74% | -30.92% | -57.1% | 12.44% | 43.68% | 18.12% | 39.63% | 60.63% | -19.46% | -36.29% | -7.86% | -52.97% | 38.85% | 167.01% | 259.22% | 185.52% | -98.98% | 11.58% | 23.33% | 63.91% | 19.95% | 13.32% | 150.31% | 35.12% | 706.67% | -73.45% |
| Net Earnings / Revenue | -29.86% | -134.73% | -265.27% | -255.5% | -4920.59% | -176.05% | -148.31% | -142.63% | -289.84% | -170.7% | -105.48% | -1125.58% | -28.17% | ||||||||||||||||
| Basic Earnings Per Share | -$0.37 | -$0.69 | -$1.39 | ||||||||||||||||||||||||||
| Diluted Earnings Per Share | -$0.37 | -$0.69 | -$1.390M | -$2.068M | -$4.152M | -$10.30M | -$31.88M | -$32.88M | -$32.71M | -$60.56M | -$99.14M | -$216.0M | -$536.0M | -$842.0M | -$914.0M | -$19.45B | -$3.487B | -$39.02B | -$26.23B | -$23.97B | -$33.20B | -$82.75B | -$102.4B | -$75.06B | -$64.70B | -$57.83B | -$28.03B | -$23.34B | -$2.904B |
Assets & Liabilities
Cash & Short-Term Investments
Loading...
Loading...
Cash & Equivalents
Loading...
Loading...
Cash To Operating Expenses Ratio
Loading...
Loading...
Inventory
Loading...
Loading...
Receivables
Loading...
Loading...
Total Short-Term Assets
Loading...
Loading...
Property, Plant And Equipment
Loading...
Loading...
Long-Term Investments
Loading...
Loading...
Total Long-Term Assets
Loading...
Loading...
Total Assets
Loading...
Loading...
Net Income To Total Assets Percentage
Loading...
Loading...
Accounts Payable
Loading...
Loading...
Short-Term Debt
Loading...
Loading...
Long Term Debt Due
Loading...
Loading...
Total Short-Term Liabilities
Loading...
Loading...
Long-Term Debt
Loading...
Loading...
Other Long-Term Liabilities
Loading...
Loading...
Total Long-Term Liabilities
Loading...
Loading...
Total Liabilities
Loading...
Loading...
Short-Term To Long-Term Debt Ratio
Loading...
Loading...
Short-Term Assets To Debt Ratio
Loading...
Loading...
Long-Term Debt To Net Income Ratio
Loading...
Loading...
Assets & Liabilities
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Short-Term Investments | $37.43M | $42.45M | $53.36M | $49.10M | $8.400M | $6.600M | $11.80M | $21.20M | $38.80M | $15.40M | $16.80M | $2.900M | $5.900M | $7.000M | $7.800M | $7.700M | $97.60M | $153.1M | $70.30M | $50.60M | $34.20M | $2.200M | $12.30M | $2.700M | $30.60M | $46.40M | $57.10M | $6.700M | $800.0K |
| YoY Change | -11.81% | -20.45% | 8.67% | 484.52% | 27.27% | -44.07% | -44.34% | -45.36% | 151.95% | -8.33% | 479.31% | -50.85% | -15.71% | -10.26% | 1.3% | -92.11% | -36.25% | 117.78% | 38.93% | 47.95% | 1454.55% | -82.11% | 355.56% | -91.18% | -34.05% | -18.74% | 752.24% | 737.5% | |
| Cash & Equivalents | $37.43M | $42.45M | $53.36M | $49.10M | $8.400M | $6.600M | $8.700M | $7.400M | $38.80M | $15.40M | $16.80M | $2.900M | $5.900M | $7.000M | $7.800M | $7.700M | $32.10M | $60.30M | $37.80M | $16.80M | $13.10M | $2.200M | $12.30M | $2.700M | $13.70M | $21.60M | $23.20M | $6.700M | $800.0K |
| Short-Term Investments | $0.00 | $3.100M | $13.80M | $65.50M | $92.80M | $32.60M | $33.80M | $21.00M | $0.00 | $17.00M | $24.90M | $33.90M | $0.00 | $0.00 | |||||||||||||||
| Other Short-Term Assets | $161.0K | $254.0K | $1.062M | $900.0K | $100.0K | $200.0K | $500.0K | $300.0K | $100.0K | $100.0K | $200.0K | $100.0K | $300.0K | $100.0K | $200.0K | $1.900M | $1.800M | $4.700M | $14.30M | $15.10M | $5.300M | $1.100M | $2.900M | $2.900M | $1.100M | $1.100M | $900.0K | $300.0K | $100.0K |
| YoY Change | -36.61% | -76.08% | 18.0% | 800.0% | -50.0% | -60.0% | 66.67% | 200.0% | 0.0% | -50.0% | 100.0% | -66.67% | 200.0% | -50.0% | -89.47% | 5.56% | -61.7% | -67.13% | -5.3% | 184.91% | 381.82% | -62.07% | 0.0% | 163.64% | 0.0% | 22.22% | 200.0% | 200.0% | |
| Inventory | |||||||||||||||||||||||||||||
| Prepaid Expenses | |||||||||||||||||||||||||||||
| Receivables | $600.0K | $8.600M | $1.200M | $300.0K | $300.0K | $600.0K | $100.0K | $0.00 | $1.300M | $700.0K | $2.200M | $100.0K | $100.0K | ||||||||||||||||
| Other Receivables | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.000M | $1.000M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $200.0K | ||||||||||||||||
| Total Short-Term Assets | $37.59M | $42.70M | $54.42M | $50.00M | $8.500M | $6.800M | $12.30M | $21.40M | $38.90M | $15.50M | $16.90M | $3.000M | $6.200M | $7.200M | $8.000M | $9.700M | $100.0M | $166.3M | $85.80M | $66.00M | $39.90M | $5.900M | $16.30M | $5.600M | $33.00M | $48.20M | $60.20M | $7.200M | $1.100M |
| YoY Change | -11.96% | -21.54% | 8.84% | 488.24% | 25.0% | -44.72% | -42.52% | -44.99% | 150.97% | -8.28% | 463.33% | -51.61% | -13.89% | -10.0% | -17.53% | -90.3% | -39.87% | 93.82% | 30.0% | 65.41% | 576.27% | -63.8% | 191.07% | -83.03% | -31.54% | -19.93% | 736.11% | 554.55% | |
| Property, Plant & Equipment | $257.0K | $368.0K | $485.0K | $400.0K | $0.00 | $0.00 | $0.00 | $100.0K | $0.00 | $0.00 | $0.00 | $0.00 | $100.0K | $700.0K | $1.000M | $1.300M | $8.900M | $12.00M | $15.20M | $6.000M | $10.00M | $15.10M | $19.00M | $12.50M | $8.400M | $6.900M | $3.900M | $1.600M | $1.000M |
| YoY Change | -30.16% | -24.12% | 21.25% | -100.0% | -100.0% | -85.71% | -30.0% | -23.08% | -85.39% | -25.83% | -21.05% | 153.33% | -40.0% | -33.77% | -20.53% | 52.0% | 48.81% | 21.74% | 76.92% | 143.75% | 60.0% | ||||||||
| Goodwill | |||||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||||
| Intangibles | |||||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||||
| Long-Term Investments | $2.400M | ||||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||||
| Other Assets | $12.00K | $18.00K | $18.00K | $0.00 | $0.00 | $0.00 | $0.00 | $800.0K | $600.0K | $600.0K | $100.0K | $100.0K | $200.0K | $300.0K | $400.0K | $100.0K | $7.100M | $0.00 | $200.0K | $500.0K | $3.900M | $1.600M | $2.100M | $2.100M | $2.100M | $2.100M | $0.00 | $0.00 | |
| YoY Change | -33.33% | 0.0% | -100.0% | 33.33% | 0.0% | 500.0% | 0.0% | -50.0% | -33.33% | -25.0% | 300.0% | -98.59% | -60.0% | -87.18% | 143.75% | -23.81% | 0.0% | 0.0% | 0.0% | ||||||||||
| Total Long-Term Assets | $269.0K | $386.0K | $503.0K | $400.0K | $0.00 | $0.00 | $100.0K | $3.200M | $700.0K | $600.0K | $200.0K | $200.0K | $300.0K | $1.000M | $1.400M | $1.400M | $20.70M | $18.10M | $22.20M | $13.30M | $17.90M | $21.20M | $23.60M | $15.70M | $12.40M | $9.700M | $6.800M | $2.200M | $1.600M |
| YoY Change | -30.31% | -23.26% | 25.75% | -100.0% | -96.88% | 357.14% | 16.67% | 200.0% | 0.0% | -33.33% | -70.0% | -28.57% | 0.0% | -93.24% | 14.36% | -18.47% | 66.92% | -25.7% | -15.57% | -10.17% | 50.32% | 26.61% | 27.84% | 42.65% | 209.09% | 37.5% | |||
| Total Assets | $37.86M | $43.09M | $54.92M | $50.40M | $8.500M | $6.800M | $12.40M | $24.60M | $39.60M | $16.10M | $17.10M | $3.200M | $6.500M | $8.200M | $9.400M | $11.10M | $120.7M | $184.4M | $108.0M | $79.30M | $57.80M | $27.10M | $39.90M | $21.30M | $45.40M | $57.90M | $67.00M | $9.400M | $2.700M |
| YoY Change | |||||||||||||||||||||||||||||
| Accounts Payable | $362.0K | $334.0K | $1.117M | $1.800M | $400.0K | $200.0K | $600.0K | $1.200M | $400.0K | $800.0K | $600.0K | $100.0K | $300.0K | $400.0K | $500.0K | $800.0K | $2.300M | $7.000M | $4.900M | $3.100M | $2.100M | $2.200M | $3.200M | $2.000M | $1.500M | $1.900M | $1.600M | $600.0K | $200.0K |
| YoY Change | 8.38% | -70.1% | -37.94% | 350.0% | 100.0% | -66.67% | -50.0% | 200.0% | -50.0% | 33.33% | 500.0% | -66.67% | -25.0% | -20.0% | -37.5% | -65.22% | -67.14% | 42.86% | 58.06% | 47.62% | -4.55% | -31.25% | 60.0% | 33.33% | -21.05% | 18.75% | 166.67% | 200.0% | |
| Accrued Expenses | $275.0K | $798.0K | $2.381M | $1.700M | $500.0K | $600.0K | $1.400M | $1.200M | $1.100M | $600.0K | $900.0K | $200.0K | $500.0K | $700.0K | $1.000M | $2.600M | $5.600M | $19.70M | $9.800M | $4.600M | $2.400M | $5.300M | $5.300M | $800.0K | $2.000M | $1.600M | $600.0K | $100.0K | $400.0K |
| YoY Change | -65.54% | -66.48% | 40.06% | 240.0% | -16.67% | -57.14% | 16.67% | 9.09% | 83.33% | -33.33% | 350.0% | -60.0% | -28.57% | -30.0% | -61.54% | -53.57% | -71.57% | 101.02% | 113.04% | 91.67% | -54.72% | 0.0% | 562.5% | -60.0% | 25.0% | 166.67% | 500.0% | -75.0% | |
| Deferred Revenue | |||||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||||
| Short-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $12.30M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | -100.0% | |||||||||||||||||||||||||||
| Long-Term Debt Due | $3.700M | $8.300M | $4.400M | $4.700M | $3.800M | $2.500M | $2.400M | $2.100M | $1.400M | $300.0K | $300.0K | $0.00 | |||||||||||||||||
| YoY Change | -55.42% | 88.64% | -6.38% | 23.68% | 52.0% | 4.17% | 14.29% | 50.0% | 366.67% | 0.0% | |||||||||||||||||||
| Total Short-Term Liabilities | $637.0K | $1.132M | $3.498M | $3.500M | $900.0K | $800.0K | $2.100M | $2.400M | $1.500M | $1.400M | $1.500M | $300.0K | $800.0K | $1.200M | $1.600M | $15.80M | $18.20M | $43.80M | $36.20M | $20.70M | $14.10M | $26.60M | $18.00M | $8.200M | $10.90M | $5.900M | $3.400M | $1.200M | $700.0K |
| YoY Change | -43.73% | -67.64% | -0.06% | 288.89% | 12.5% | -61.9% | -12.5% | 60.0% | 7.14% | -6.67% | 400.0% | -62.5% | -33.33% | -25.0% | -89.87% | -13.19% | -58.45% | 20.99% | 74.88% | 46.81% | -46.99% | 47.78% | 119.51% | -24.77% | 84.75% | 73.53% | 183.33% | 71.43% | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $100.0K | $3.800M | $11.10M | $15.50M | $5.000M | $6.200M | $4.700M | $5.200M | $4.500M | $600.0K | $800.0K | $0.00 |
| YoY Change | -100.0% | -97.37% | -65.77% | -28.39% | 210.0% | -19.35% | 31.91% | -9.62% | 15.56% | 650.0% | -25.0% | ||||||||||||||||||
| Other Long-Term Liabilities | $204.0K | $280.0K | $383.0K | $400.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $200.0K | $300.0K | $600.0K | $34.80M | $70.60M | $11.30M | $1.900M | $5.600M | $0.00 | $100.0K | $0.00 | ||||||
| YoY Change | -27.14% | -26.89% | -4.25% | -100.0% | -33.33% | -50.0% | -98.28% | -50.71% | 524.78% | 494.74% | -66.07% | -100.0% | |||||||||||||||||
| Total Long-Term Liabilities | $204.0K | $280.0K | $383.0K | $400.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $200.0K | $300.0K | $600.0K | $34.80M | $70.70M | $15.10M | $13.00M | $21.10M | $5.000M | $6.300M | $4.700M | $5.200M | $4.500M | $600.0K | $800.0K | $0.00 |
| YoY Change | -27.14% | -26.89% | -4.25% | -100.0% | -33.33% | -50.0% | -98.28% | -50.78% | 368.21% | 16.15% | -38.39% | 322.0% | -20.63% | 34.04% | -9.62% | 15.56% | 650.0% | -25.0% | |||||||||||
| Total Liabilities | $841.0K | $1.412M | $3.881M | $3.900M | $900.0K | $800.0K | $2.100M | $2.400M | $1.500M | $1.400M | $1.500M | $300.0K | $800.0K | $1.400M | $2.000M | $16.40M | $53.00M | $114.6M | $51.30M | $33.70M | $35.10M | $31.60M | $24.50M | $12.90M | $16.10M | $10.30M | $4.000M | $2.000M | $800.0K |
| YoY Change | -40.44% | -63.62% | -0.49% | 333.33% | 12.5% | -61.9% | -12.5% | 60.0% | 7.14% | -6.67% | 400.0% | -62.5% | -42.86% | -30.0% | -87.8% | -69.06% | -53.75% | 123.39% | 52.23% | -3.99% | 11.08% | 28.98% | 89.92% | -19.88% | 56.31% | 157.5% | 100.0% | 150.0% |
Ownership
Basic Shares Outstanding
Loading...
Loading...
Diluted Shares Outstanding
Loading...
Loading...
Preferred Stock
Loading...
Loading...
Treasury Stock Shares
Loading...
Loading...
Stock Issuance & Repurchase
Loading...
Loading...
Ownership Data
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Basic Shares Outstanding | 14.42M | 14.41M | 13.90M | 20.50M | 8.632M | 2.226M | |||||||||||||||||||||||
| Diluted Shares Outstanding | 14.42M | 14.41M | 13.90M | ||||||||||||||||||||||||||
| Preferred Stock | |||||||||||||||||||||||||||||
| Treasury Stock Shares |
Return On Shareholders' Equity
Loading...
Loading...
Book Value
Loading...
Loading...
Free Cash Flow
Loading...
Loading...
Free Cash Flow YoY
Loading...
Loading...
Free Cash Flow Margin
Loading...
Loading...
Dividends
Dividends
Loading...
Loading...
Stock Price
Loading...
Market Cap: $34.82 Million
About Oruka Therapeutics, Inc.
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The company is headquartered in Westminster, Colorado and currently employs 4 full-time employees. The company went IPO on 2000-07-21. The firm's lead product candidate is Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation (AF) in patients with chronic heart failure (HF). Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. Gencaro is a pharmacogenetically-targeted beta-adrenergic receptor antagonist with mild vasodilator properties that is developing for the treatment of atrial fibrillation in patients with heart failure. Its Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), is a protein therapeutic in clinical development as a potential treatment for patients with COVID-19. The company is also evaluating options for development of its assets, including partnering and other strategic options.
Industry: In Vitro & In Vivo Diagnostic Substances Peers: ABVC BIOPHARMA, INC. AIM ImmunoTech Inc. Ainos, Inc. Aravive, Inc. Codiak BioSciences, Inc. GLYCOMIMETICS INC Harpoon Therapeutics, Inc. Pasithea Therapeutics Corp.
